Innate Pharma S.A. Sponsored ADR (IPHA)

Last Closing Price: 1.56 (2026-10-02)

Debt to Capital Ratio (Quarterly)

Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)

Innate Pharma S.A. Sponsored ADR (IPHA) Debt to Capital Ratio data is not available.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Balance Sheet Financials
$22.79M
$4.24M
$17.59M
$40.38M
$38.20M
$10.95M
$49.27M
$87.47M
$-47.10M
$-47.10M
$-47.10M
93.92M
Cash Flow Statement Financials
$-24.47M
$2.36M
$-2.75M
$32.66M
$7.51M
$-25.15M
$1.25M
--
--
Fundamental Metrics & Ratios
--
--
--
Debt to Capital Ratio
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--